Scarce evidence of efficacy of hyperbaric oxygen therapy in necrotizing soft tissue infection: a systematic review

References

• Wilson B. Necrotizing fasciitis. Am Surg. 1952;18:416–431.
   PubMedGoogle Scholar
• Khamnuan P, Chongruksut W, Jearwattanakanok K, et al. Necrotizing fasciitis: epidemiology and clinical predictors for amputation. Int J Gen Med. 2015;8:195–202.
   PubMed Web of Science ®Google Scholar
• Naseer U, Steinbakk M, Blystad H, et al. Epidemiology of invasive group A streptococcal infections in Norway 2010–2014: a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2016;35:1639–1648.
   PubMed Web of Science ®Google Scholar
• Glass GE, Sheil F, Ruston JC, et al. Necrotising soft tissue infection in a UK metropolitan population. Ann R Coll Surg Engl. 2015;97:46–51.
   PubMed Web of Science ®Google Scholar
• Bocking N, Matsumoto CL, Loewen K, et al. High incidence of invasive group A streptococcal infections in remote indigenous communities in northwestern Ontario, Canada. Open Forum Infect Dis. 2016;4:ofw243.
   PubMed Web of Science ®Google Scholar
• Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2017;377:2253–2265.
   PubMed Web of Science ®Google Scholar
• Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44:705–710.
   PubMed Web of Science ®Google Scholar
• Wong CH, Chang HC, Pasupathy S, et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85-A:1454–1460.
   PubMed Web of Science ®Google Scholar
• Devaney B, Frawley G, Frawley L, et al. Necrotising soft tissue infections: the effect of hyperbaric oxygen on mortality. Anaesth Intensive Care. 2015;43:685–692.
   PubMed Web of Science ®Google Scholar
• Thrane JF, Pikelis A, Ovesen T. Hyperbaric oxygen may only be optional in head and neck necrotizing fasciitis: a retrospective analysis of 43 cases and review of the literature. Infect Dis (Lond). 2017;49:792–798.
   PubMed Web of Science ®Google Scholar
• de Prost N, Sbidian E, Chosidow O, et al. Management of necrotizing soft tissue infections in the intensive care unit: results of an international survey. Intensive Care Med. 2015;41:1506–1508.
   PubMed Web of Science ®Google Scholar
• Linnér A, Darenberg J, Sjölin J, et al. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Inf Dis. 2014;59:851–857.
   PubMed Web of Science ®Google Scholar
• Skansén-Saphir U, Andersson J, Björk L, et al. Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively down-regulated by pooled human IgG. Eur J Immunol. 1994;24:916–922.
   PubMed Web of Science ®Google Scholar
• Madsen MB, Hjortrup PB, Hansen MB, et al. Immunoglobulin G for necrotising soft tissue infections (INSTINCT): a randomised, blinded, placebo-controlled trial. Intensive Care Med. 2017;43:1585–1593.
   PubMed Web of Science ®Google Scholar
• Sharkey LS. Current indications for hyperbaric oxygen therapy. ADF Heal. 2000;1:64–72.
   Google Scholar
• Hyperbaric Oxygen Therapy (HBOT). Devices/equipment market analysis by product (Monoplace, Multiplace, Topical HBOT Devices), by application (Wound Healing, Infection Treatment, Gas Embolism), and segment forecast, 2018–2025. Grand View Research (US); 2017 (Report ID: GVR-1-68038-845-9)
   Google Scholar
• Weaver LK. UHMS hyperbaric oxygen therapy indications. 13th ed. North Palam Beach (FL): Best Publishing Company; 2014.
   Google Scholar
• Shah J. Hyperbaric oxygen therapy. J Am Col Certif Wound Spec. 2010;2:9–13.
   PubMedGoogle Scholar
• Camporesi E, Bosco G. Mechanisms of action of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014;41:247–252.
   PubMed Web of Science ®Google Scholar
• Weaver LK. Hyperbaric medicine for the hospital-based physician. Hosp Pract (1995). 2012;40:88–101.
   PubMedGoogle Scholar
• Cimşit M, Uzun G, Yildiz S. Hyperbaric oxygen therapy as an anti-infective agent. Expert Rev Anti Infect Ther. 2009;7:1015–1026.
   PubMed Web of Science ®Google Scholar
• Memar MY, Ghotaslou R, Samiei M, et al. Antimicrobial use of reactive oxygen therapy: current insights. Infect Drug Resist. 2018;11:567–576.
   PubMed Web of Science ®Google Scholar
• Plafki C, Peters P, Almeling M, et al. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med. 2000;71:119–124.
   PubMedGoogle Scholar
• Lo T, Song C, Alismail A, et al. Hyperbaric oxygen therapy: how safe is it for critically ill patients? Crit Care Med. 2014;42:A1520.
   Google Scholar
• Smerz RW. Incidence of oxygen toxicity during the treatment of dysbarism. Undersea Hyperb Med. 2004;31:199–202.
   PubMedGoogle Scholar
• Stevens D, Bisno A, Chambers H, et al. Executive summary: practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Inf Dis. 2014;59:147–159.
   PubMed Web of Science ®Google Scholar
• Levett D, Bennett MH, Millar I. Adjunctive hyperbaric oxygen for necrotizing fasciitis. Cochrane Database Syst Rev. 2015;1:CD007937.
   PubMedGoogle Scholar
• Jallali N, Withey S, Butler PE. Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg. 2005;189:462–466.
   PubMed Web of Science ®Google Scholar
• Wang CC, Schwaitzberg S, Berliner E, et al. Hyperbaric oxygen for treating wounds: a systematic review of the literature. Arch Surg. 2003;138:272–279.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Prospero. [Internet] Cited 2019 Available from:http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015021972
   Google Scholar
• Moga C, Guo B, Schopflocher D, et al. Development of a quality appraisal tool for case series studies using a modified Delphi technique. Edmont AB Inst Heal Econ. 2012.
   Google Scholar
• Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
   PubMed Web of Science ®Google Scholar
• Pagano MG. Principles of biostatistics. 2nd ed. Belmont (CA): Brooks/Cole.; 2000.
   Google Scholar
• Mao JC, Carron MA, Fountain KR, et al. Craniocervical necrotizing fasciitis with and without thoracic extension: management strategies and outcome. Am J Otolaryngol. 2009;30:17–23.
   PubMed Web of Science ®Google Scholar
• Mindrup SR, Kealey GP, Fallon B. Hyperbaric oxygen for the treatment of Fournier’s gangrene. J Urol. 2005;173:1975–1977.
   PubMed Web of Science ®Google Scholar
• Shupak A, Shoshani O, Goldenberg I, et al. Necrotizing fasciitis: an indication for hyperbaric oxygenation therapy? Surgery. 1995;118:873–878.
   PubMed Web of Science ®Google Scholar
• Shaw JJ, Psoinos C, Emhoff TA, et al. Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections. Surg Infect (Larchmt). 2014;15:328–335.
   PubMed Web of Science ®Google Scholar
• Soh CR, Pietrobon R, Freiberger JJ, et al. Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample. Intensive Care Med. 2012;38:1143–1151.
   PubMed Web of Science ®Google Scholar
• Wilkinson D, Doolette D. Hyperbaric oxygen treatment and survival from necrotizing soft tissue infection. Arch Surg. 2004;139:1339–1345.
   PubMedGoogle Scholar
• Phan HH, Cocanour CS. Necrotizing soft tissue infections in the intensive care unit. Crit Care Med. 2010;38:S460–S468.
   PubMed Web of Science ®Google Scholar
• Mills MK, Faraklas I, Davis C, et al. Outcomes from treatment of necrotizing soft-tissue infections: results from the National Surgical Quality Improvement Program database. Am J Surg. 2010;200:790–796.
   PubMed Web of Science ®Google Scholar
• Bulger EM, May A, Dankner W, et al. Validation of a clinical trial composite endpoint for patients with necrotizing soft tissue infections. J Trauma Acute Care Surg. 2017;83:622–627.
   PubMed Web of Science ®Google Scholar
• Madsen MB, Skrede S, Bruun T, et al. Necrotizing soft tissue infections – a multicentre, prospective observational study (INFECT): protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2018;62:272–279.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [Internet]. Identifier NCT02469857. Phase III efficacy and safety study of AB103 in the treatment of patients with necrotizing soft tissue infections (ACCUTE). Bethesda (MD): National Library of Medicine; 2015. 2000 Feb 29, June 12. [cited 2019 Jan 30]. Available from: https://clinicaltrials.gov/ct2/show/NCT02469857
   Google Scholar
• ClinicalTrials.gov [Internet]. Identifier NCT03147352. Prognosis and treatment of necrotizing soft tissue infections: a prospective cohort study (ProTreat). Bethesda (MD): National Library of Medicine; 2017. 2000 Feb 29, May 10. [Cited 2019 Jan 30]. Available from: https://clinicaltrials.gov/ct2/show/NCT0314735
   Google Scholar
• Anheuser P, Mühlstädt S, Kranz J, et al. Significance of hyperbaric oxygenation in the treatment of Fournier’s gangrene: a comparative study. Urol Int. 2018;101:467–471.
   PubMed Web of Science ®Google Scholar
• Ayan F, Sunamak O, Paksoy SM, et al. Fournier’s gangrene: a retrospective clinical study on forty-one patients. ANZ J Surg. 2005;75:1055–1058.
   PubMed Web of Science ®Google Scholar
• Brown DR, Davis NL, Lepawsky M, et al. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg. 1994;167:485–489.
   PubMed Web of Science ®Google Scholar
• Dahm P, Roland FH, Vaslef SN, et al. Outcome analysis in patients with primary necrotizing fasciitis of the male genitalia. Urology. 2000;56:31–36.
   PubMed Web of Science ®Google Scholar
• George ME, Rueth NM, Skarda DE, et al. Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infection. Surg Infect (Larchmt). 2009;10:21–28.
   PubMed Web of Science ®Google Scholar
• Hassan Z, Mullins RF, Friedman BC, et al. Treating necrotizing fasciitis with or without hyperbaric oxygen therapy. Undersea Hyperb Med. 2010;37:115–123.
   PubMed Web of Science ®Google Scholar
• Hollabaugh RS, Jr. Dmochowski RR, Hickerson WL, et al. Fournier’s gangrene: therapeutic impact of hyperbaric oxygen. Plast Reconstr Surg. 1998;101:94–100.
   PubMed Web of Science ®Google Scholar
• Hung MC, Chou CL, Cheng LC, et al. The role of hyperbaric oxygen therapy in treating extensive Fournier’s gangrene. Urol Sci. 2016;27:148–153.
   Web of Science ®Google Scholar
• Krenk L, Nielsen HU, Christensen ME. Necrotizing fasciitis in the head and neck region: an analysis of standard treatment effectiveness. Eur Arch Otorhinolaryngol. 2007;264:917–922.
   PubMed Web of Science ®Google Scholar
• Li C, Zhou X, Liu LF, et al. Hyperbaric oxygen therapy as an adjuvant therapy for comprehensive treatment of Fournier’s gangrene. Urol Int. 2015;94:453–458.
   PubMed Web of Science ®Google Scholar
• Massey PR, Sakran JV, Mills AM, et al. Hyperbaric oxygen therapy in necrotizing soft tissue infections. J Surg Res. 2012;177:146–151.
   PubMed Web of Science ®Google Scholar
• Mehl AA, Nogueira Filho DC, Mantovani LM, et al. Management of Fournier’s gangrene: experience of a university hospital of Curitiba. Rev Col Bras Cir. 2010;37:435–441.
   PubMedGoogle Scholar
• Riseman JA, Zamboni WA, Curtis A, et al. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery. 1990;108:847–850.
   PubMed Web of Science ®Google Scholar